Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 4/20 | 0.41 |
| ▸ | F10 | P00742 | 4/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.35 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.35 |
| ▸ | FEN1 | P39748 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13586276 | 0.94 | FFAR4 (0.37) | FFAR1F10NR1H4FFAR4MAOB | |
| SCHEMBL13586476 | 0.91 | FFAR1 (0.38) | FFAR1F10NR1H4FFAR4MAOB | |
| SCHEMBL12822845 | 0.87 | F10 (0.36) | FFAR1F10NR1H4FFAR4MAOB | |
| SCHEMBL13586391 | 0.87 | FFAR1 (0.38) | FFAR1F10NR1H4FFAR4MAOB | |
| SCHEMBL12821293 | 0.86 | FEN1 (0.36) | FFAR1FFAR4ALOX5APFEN1 | |
| SCHEMBL12822960 | 0.86 | FEN1 (0.36) | FFAR1FFAR4ALOX5APFEN1 | |
| SCHEMBL12823864 | 0.86 | FFAR1 (0.40) | FFAR1F10FFAR4MAOBMAOA | |
| SCHEMBL13586613 | 0.86 | BRD4 (0.36) | FFAR4 | |
| SCHEMBL12822841 | 0.85 | FFAR1 (0.42) | FFAR1F10FFAR4 | |
| SCHEMBL12822757 | 0.85 | F10 (0.35) | FFAR1F10NR1H4FFAR4MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009150966-A1 | TETRACYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | チッソ株式会社 (JP) | 2009-12-17 | — | — | WO | disclosed |